Bariatric surgery patients tend to see about five times more weight loss than weekly injections of GLP-1s at the end of two years according to a new study
Read More From Croatia to MAHA: How an unapproved drug became the next hot peptide: For an interesting read on the backstory, check out this fantastic investigative piece by journalist Sara Talpos for Undark in collaboration with STAT News .
Real World Data Beyond Clinical Trials Clinical trials provide controlled environments with strict monitoring, but real world data captures how GLP-1 medications perform in everyday use
Early research suggests retatrutide may produce greater weight loss in some cases, but long-term comparative studies are still ongoing
Zepbound contains Tirzepatide, which acts on both GIP and GLP-1 receptors to reduce weight, while Semaglutide acts only on GLP-1 receptors
History of Failed Weight Loss Attempts: Many healthcare providers will recommend Semaglutide for patients who have tried traditional weight loss methods (diet and exercise) but have not achieved significant or sustainable results